Events|

SHL joins Partnership Opportunities in Drug Delivery

Press Release 201909 Podd

SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) conference from October 7-8 in Boston.

The company’s debut exhibit will feature a vast array of products that provide solutions for the growing demands in self-injection treatments. Displays include Needle Isolation Technology (NIT®) – a pre-attached needle mechanism for cartridge-based autoinjectors that eliminates the need for users to manually attach the needle or directly contact with the needle upon injection preparation; the refined Molly® variation – an autoinjector family that offers devices for drug fill volumes up to 2.25mL and is designed to be mass-produced effectively and efficiently.

Owning 30 years of experience and industry knowledge, SHL continues to thrive in the self-injection treatment space, offering pharma companies a broad scope of services that include the design, development, and manufacturing of advanced drug delivery systems.

Visit SHL at Booth 24 at the Renaissance Boston Waterfront Hotel.

About SHL

SHL Group is a world-leading solution provider in the design, development and manufacturing of advanced drug delivery devices such as autoinjectors, pen injectors and advanced inhaler systems. We also offer core competencies and services in the fields of medtech and patient care solutions. With locations in Taiwan, Switzerland, Sweden, China and the US, our experienced engineers and designers develop product enhancements as well as breakthrough drug delivery and patient care solutions for pharma and biotech clients globally. Significant investment in R&D has enhanced our broad pipeline of next-generation drug delivery systems that support ongoing innovations in drug development and digital healthcare. This includes advanced reusable and disposable injectors that can accommodate high volume and high viscosities and can be enhanced through digital implementations.

With over 4,800 employees worldwide, SHL Group consists of several distinct group companies:

SHL Medical designs, develops and manufactures advanced drug delivery devices, as well as provides final assembly, labeling and packaging services for leading pharmaceutical and biotech companies across the globe.

SHL Healthcare develops and manufactures equipment solutions for home, hospital and long term care use.

SHL Technologies provides contract manufacturing and engineering services for the production of complex medtech and industrial products.

For additional information, visit www.shl.group

 

Share:

Related News